NCT07439081Completed
OPTIMUM Study of Remote Patient Monitoring in Ambulatory Heart Failure Care
OPTIMUM: OPTIMisation du Parcours de Soins du Patient Insuffisant Cardiaque Chronique
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
Heart failure is a leading cause of hospitalization and readmission, particularly among older adults with multiple comorbidities. Traditional outpatient follow-up may be insufficient to detect early clinical deterioration in this vulnerable population. Remote patient monitoring (RPM) using non-invasive symptom and weight tracking has been proposed to enhance ambulatory care, but its effectiveness appears to depend on integration within structured care pathways. The OPTIMUM study evaluated the real-world implementation of an integrated ambulatory heart failure care pathway combining non-invasive RPM with multidisciplinary follow-up in routine clinical practice. Patients enrolled after a recent heart failure hospitalization were managed using the Satelia® Cardio monitoring system, nurse-led therapeutic education, and a planned cardio-geriatric day-hospital reassessment. The study aimed to describe pathway implementation and assess associations with rehospitalizations, mortality, alert activity, and patient and healthcare professional satisfaction in an older, frail population.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 504 (actual)
- First submitted
- 6 Feb 2026
- Start date
- 1 Jan 2021
- Primary completion date
- 1 Jul 2023
- Lead sponsor
- Médipôle Lyon-Villeurbanne
- Diseases
- Heart failure
- NCT number
- NCT07439081
What you commit to
- Study type: Interventional
- Participants enrolled: 504
- From 1 Jan 2021 to the primary completion date, 1 Jul 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of a non-cardiac comorbidity associated with an estimated life expectancy of less than 12 months
Other
- Inability to provide informed consent
- Refusal to participate in remote patient monitoring or the OPTIMUM care pathway
- Physical, cognitive, or psychological limitations incompatible with use of the remote monitoring system
- Treating clinician judged that adherence to telemonitoring would be insufficient
Who the study is looking for
- Age ≥18 years
- Diagnosis of heart failure
- Hospitalization for acute heart failure or a cardiac cause OR outpatient evaluation with a history of heart-failure hospitalization within the previous 12 months
- Enrollment into the OPTIMUM ambulatory heart failure care pathway
- Ability to provide informed consent
- Agreement to participate in remote patient monitoring
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Médipôle Hôpital Mutualiste Coordinator of this site? Confirm its status | Lyon | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.